CEA, or carcinoembryonic antigen, is a protein found on the surface of cells that plays a role in cell adhesion, helping cells stick together. In medical practice, CEA is best known as a blood test used primarily to monitor cancer treatment and detect cancer recurrence, especially in colorectal cancer. Normal levels fall between 0 and 3 ng/mL for non-smokers, or up to 5 ng/mL for smokers.
What CEA Actually Is
CEA is a glycoprotein, a protein with sugar molecules attached to it, that sits on the surface of cells. It belongs to a larger family of proteins called carcinoembryonic antigen-related cell adhesion molecules (CEACAMs), which are part of the immunoglobulin superfamily. These proteins help cells communicate with each other and bind together, which is essential for building and maintaining tissue structure.
During fetal development, CEA proteins are produced in large amounts because cell adhesion is critical for integrating cells into functional organs. After birth, healthy adult tissues produce CEA at much lower levels. When CEA shows up in elevated amounts in an adult’s bloodstream, it can signal that something is driving cells to overproduce it, whether that’s cancer, inflammation, or another condition.
How CEA Works in the Body
CEA proteins anchor themselves to the outer surface of cells, where they act as a kind of molecular velcro. They can bind to identical CEA proteins on neighboring cells (homotypic binding) or connect with different types of receptor proteins like integrins (heterotypic binding). This dual capability lets CEA influence not just how tightly cells stick together but also how cells send and receive signals about growth, movement, and survival.
The CEA family also includes a group of proteins secreted during pregnancy that help regulate interactions between the mother’s immune system and the developing fetus. Beyond adhesion and pregnancy, CEA family members play roles in immune function, blood vessel formation, and blood sugar regulation.
Why Doctors Order a CEA Blood Test
The primary clinical use of CEA is monitoring, not screening. Doctors rarely use it to find cancer in the first place because it isn’t specific enough. Instead, CEA becomes valuable after a cancer diagnosis, particularly colorectal cancer, in two key situations.
First, before surgery: a high preoperative CEA level can flag advanced disease that imaging might miss. Higher levels correlate with more advanced stage, lymph node spread, and worse survival outcomes. Second, after surgery: serial CEA measurements help detect recurrence. In post-surgical follow-up for colorectal cancer, blood is typically drawn every six months starting three months after the operation. When levels start climbing after having been normal, it can be an early warning that cancer has returned, sometimes before symptoms appear or imaging picks anything up.
As a monitoring tool for recurrent colorectal cancer, serial CEA testing catches about 80% of recurrences with a specificity of roughly 70%. That’s useful but imperfect, which is why CEA is always interpreted alongside imaging and other clinical information rather than on its own.
Cancers That Raise CEA Levels
Colorectal cancer is the most common reason for elevated CEA, but it’s far from the only one. CEA can rise in breast cancer, lung cancer, ovarian cancer (particularly the mucinous type), cervical cancer, medullary thyroid cancer, and other gastrointestinal tumors like stomach and pancreatic cancers.
For medullary thyroid cancer, CEA plays a supporting role. It’s not specific enough to diagnose the disease, but tracking levels after thyroid removal helps doctors gauge whether the cancer is progressing or responding to treatment. In metastatic breast cancer, CEA is sometimes monitored alongside other tumor markers to evaluate how well treatment is working.
Non-Cancer Causes of Elevated CEA
An elevated CEA result doesn’t automatically mean cancer. Several benign conditions can push levels above the normal range, which is one reason CEA isn’t useful as a standalone screening tool.
- Smoking: Cigarette use is one of the most common causes of mildly elevated CEA, which is why the normal threshold for smokers is set higher at 5 ng/mL instead of 3 ng/mL.
- Inflammatory bowel disease: Conditions like Crohn’s disease and ulcerative colitis can elevate CEA due to chronic intestinal inflammation.
- Liver problems: Cirrhosis, liver dysfunction, and biliary tract disorders including chronic gallbladder inflammation are known to raise levels.
- Lung disease: Chronic obstructive pulmonary disease (COPD) can cause mild CEA elevation.
- Other digestive conditions: Peptic ulcer disease and certain medications may also contribute to higher readings.
Because so many non-cancerous conditions affect CEA, a single elevated reading needs context. Your doctor will consider your medical history, smoking status, and whether levels are trending upward over time rather than reacting to one number in isolation.
What CEA Cannot Do
CEA is a poor early detection tool. It has little value in finding colorectal cancer at an early, curable stage, which is why no major guidelines recommend it for routine cancer screening in the general population. Early-stage colorectal cancers often produce normal or only slightly elevated CEA levels, meaning a “normal” result can be falsely reassuring. The test shines only after a diagnosis has been made, where its ability to track trends over time becomes genuinely useful for catching recurrence and evaluating treatment response.
It’s also nonspecific. A high CEA level can’t tell you which organ is affected or whether the cause is cancer at all. It raises a flag, and further testing, usually imaging, determines what that flag means.